Markets
27th SCAD Savannah Film Festival - Portraits
James Carville, who famously quipped, “It’s the economy, stupid!” (Emma McIntyre/Getty Images)

Is it really just the earnings, stupid?*

*in which “stupid” is a reference to the author.

Luke Kawa

The major bounce-back in US stocks that started with tariff relief has received a welcome fundamental boost during this reporting period.

Ahead of Q1 results, I hypothesized that this earnings season wouldn’t really be about earnings. It would be about tariffs: whether companies saw a rush of activity from customers trying to beat the imposition of levies and how their outlooks had changed in light of the upheaval to trade — if they deigned to even offer an outlook at all.

Q1 results, in other words, had the potential to be a bit of a head-fake about a world that was no longer going to exist.

And, well, there is some support for that thesis. Companies that do well aren’t seeing their stocks soar, by and large, perhaps because of that aforementioned line of thinking or because the solid results came along with underwhelming guidance.

“Companies which have beaten on both EPS and sales have outperformed the S&P 500 by 0.2ppt the following day, well below the historical average of 1.5ppt — suggesting 1Q results matter less amid looming uncertainty over tariffs/the macro and the potential impact on the rest of the year,” wrote Savita Subramanian, head of US equity and quantitative strategy at Bank of America. “Misses have underperformed by 3.9ppt the subsequent day, more than the historical average of 2.5ppt.”

Q1 results, in other words, had the potential to be a bit of a head-fake about a world that was no longer going to exist.

But that may be missing the forest for the trees here when it comes to telling another simple story about earnings season: it’s been really good!

In aggregate, earnings have surprised to the upside by a colossal amount.

So far, profits per share have exceeded expectations by a whopping 9.3% among S&P 500 companies that have reported, per Bloomberg data.

That’s the best in at least the past couple years, and contrasts wildly with what analysts had been doing in a frenzied fashion ahead of earnings season: chopping estimates more often than they had since Covid.

Sales, it should be noted, are exceeding expectations by much less than earnings. What this tells us is that companies were great at managing margins (yet again!), maximizing their earnings for every dollar of sales. This may become a challenge in the event that tariffs push input costs materially higher.

But markets are always (supposedly) forward-looking. And what they seem to be looking forward to is a world where tariffs aren’t as high as traders would have feared a few short weeks ago, they might be going down even more, and Corporate America is in a much better starting position than previously thought to grapple with whatever awaits.

On the other hand, the fact that the S&P 500’s best performer since the April 8 lows by a considerable margin is Palantir — a company driven more by retail enthusiasm than staid reevaluations of the discounted value of its projected future cash flows — does seem to severely undercut purely fundamental-based explanations to unpack the market move. As does the stronger recovery for the iShares MSCI USA Momentum Factor ETF compared to baskets of the most tariff-affected stocks.

Oh well, we tried.

More Markets

See all Markets
markets

Intel jumps on report of customer talks with AMD for foundry division

Intel shares popped in afternoon trading Wednesday after Semafor reported that Intel is in preliminary talks with AMD to come aboard as a customer for Intel’s troubled contract chip manufacturing division, known as a foundry.

Shares were recently up 5.7%.

Semafor stressed that sources said “it’s unclear how much of their manufacturing would shift to Intel if the two companies reach a deal, or whether it would come with a direct investment by AMD, similar to the deals cut by other companies. It is possible that no agreement will be reached, the people said.”

The addition of AMD — which competes with Intel in the CPU space — as a customer would be another big win for the US chipmaker following its partnership with Nvidia announced in mid-September.

TSMC, the primary manufacturer of AMD chips, was only briefly rattled by the news, and remains well in the green on the day.

Semafor stressed that sources said “it’s unclear how much of their manufacturing would shift to Intel if the two companies reach a deal, or whether it would come with a direct investment by AMD, similar to the deals cut by other companies. It is possible that no agreement will be reached, the people said.”

The addition of AMD — which competes with Intel in the CPU space — as a customer would be another big win for the US chipmaker following its partnership with Nvidia announced in mid-September.

TSMC, the primary manufacturer of AMD chips, was only briefly rattled by the news, and remains well in the green on the day.

markets

ChargePoint jumps as EV sales soar

Riding along with some other EV stocks, shares of ChargePoint jumped 4.1% in recent trading. The last rush to take advantage of Biden-era federal EV incentives has put a bunch of new EVs on the road, sending ChargePoint up, along with Tesla, Rivian, and Lucid.

Ford said earlier Wednesday that its EV sales hit a quarterly record, and it and other EV makers have been exploring unorthodox ways to replicate the EV tax credits for consumers through year end.

Still, ChargePoint is down over 47% for the year, and narrowly escaped NYSE delisting with a 20-1 reverse stock split back in July. And it’s not hard to see why: The company has never had a profitable quarter.

markets

Trump admin reportedly backs off on pharma tariffs

The Trump Administration will not be imposing tariffs on pharmaceutical companies by the deadline it had initially given them, a White House official told STAT.

Last week, President Trump announced on Truth Social that starting on October 1 there will be a 100% tariff on patented, branded pharmaceuticals “unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America." As of October 1, those tariffs have not gone into effect and its unclear when they will, according to STAT.

markets

GE Vernova declines after analyst downgrade of top AI energy trade

Power turbine maker GE Vernova is down midday after RBC analysts cut their rating on the stock from “outperform” (essentially a “buy”) to “sector perform” (essentially a “hold”), suggesting that long-term earnings expectations for the company might have gotten too optimistic.

RBC’s Christopher Dendrinos wrote:

“Our longer-term expectations are more conservative than consensus expectations which we think could be over appreciating the cadence of revenue growth in the power segment in 2029-2030. We believe investors are already fully valuing the company on the longer-term 2030 outlook and there could be more limited opportunity for positive rate of change in current expectations.”

Dendrinos argues that the Street’s expectations for when the river of payments will materialize from the service contracts GE sells to maintain the newly installed turbines is too soon. He wrote that it will take a much longer cycle:

“Mgmt sees an opportunity to double the installed base of baseload power over the next 10 years which should support significant rev growth and stronger margins (we estimate gas service margins over 30%).

However, the first major service cycle typically occurs ~3-4 years after installation so the benefit of service price increases and new LTSAs are unlikely to begin to benefit the income statement until later in the decade and will be a gradual increase.”

Earlier in the year, GE Vernova was a top performer as the AI data center trade boomed. It was up roughly 100% for the year in late July, making it the third-best gainer in the S&P 500 for the year.

It has stalled since then, though it remains up more than 80% in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.